NCT06226272 Clinical Outcome Measure at Stryker Spine
| NCT ID | NCT06226272 |
| Status | Recruiting |
| Phase | — |
| Sponsor | VB Spine, LLC |
| Condition | Degenerative Disc Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,222 participants |
| Start Date | 2025-01-28 |
| Primary Completion | 2029-01-29 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,222 participants in total. It began in 2025-01-28 with a primary completion date of 2029-01-29.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a multicenter, prospective, retrospective, Post Market Clinical Follow-up (PMCF) study in subjects who have undergone or will undergo surgery utilizing one or more Stryker devices according to Stryker cleared Instructions for Use (IFU).
Eligibility Criteria
Inclusion Criteria: • To be eligible to participate in the study, the potential subject must meet all inclusion criteria specific to the Stryker system being evaluated, please contact one of the participating investigators or see the device-specific cleared IFU, for further details. Exclusion Criteria: • The exclusion criteria are based on the contraindications as presented in the Stryker device cleared IFUs, please contact one of the participating investigators or see the device-specific cleared IFU, for further details.
Contact & Investigator
Jad G. Khalil, MD
PRINCIPAL INVESTIGATOR
Michigan Orthopaedic Surgeons
Frequently Asked Questions
Who can join the NCT06226272 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Degenerative Disc Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06226272 currently recruiting?
Yes, NCT06226272 is actively recruiting participants. Contact the research team at mary.majer@vbspineco.com for enrollment information.
Where is the NCT06226272 trial being conducted?
This trial is being conducted at Jacksonville, United States, Scarborough, United States, Southfield, United States, Cleveland, United States and 3 additional locations.
Who is sponsoring the NCT06226272 clinical trial?
NCT06226272 is sponsored by VB Spine, LLC. The principal investigator is Jad G. Khalil, MD at Michigan Orthopaedic Surgeons. The trial plans to enroll 5,222 participants.